A - Agilent Technologies Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Agilent Technologies Inc.
Agilent Technologies Inc is engaged in life sciences, diagnostics and applied chemical markets. The company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.
IPO Date: November 19, 1999
Sector: Healthcare
Industry: Diagnostics and Research
Market Cap: $44.11B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.83 | 1.29%
Avg Daily Range (30 D): $2.20 | 1.46%
Avg Daily Range (90 D): $2.11 | 1.56%
Institutional Daily Volume
Avg Daily Volume: 2.31M
Avg Daily Volume (30 D): 1.6M
Avg Daily Volume (90 D): 1.69M
Trade Size
Avg Trade Size (Sh.): 127
Avg Trade Size (Sh.) (30 D): 46
Avg Trade Size (Sh.) (90 D): 47
Institutional Trades
Total Institutional Trades: 46,514
Avg Institutional Trade: $3.93M
Avg Institutional Trade (30 D): $17.45M
Avg Institutional Trade (90 D): $15.81M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 8
Market Closing Trades
Avg Closing Trade: $19.23M
Avg Closing Trade (30 D): $72.5M
Avg Closing Trade (90 D): $68.07M
Avg Closing Volume: 204.66K
 
News
Sep 4, 2026 @ 9:48 AM
Global Multiplex Assays Market 2026 Edition - Con...
Source: Researchandmarkets.Com
Aug 31, 2026 @ 1:15 PM
International Markets and Agilent (A): A Deep Dive...
Source: Na
Aug 27, 2026 @ 3:00 PM
Laboratory Informatics Market to Grow from USD 4.0...
Source: Sns Insider
Aug 6, 2026 @ 9:30 PM
[Latest] Global gRNA Market Size/Share Worth USD 2...
Source: Custom Market Insights
Aug 6, 2026 @ 2:52 PM
AI Disruption Reshapes Bioinformatics: Record Inve...
Source: Bcc Research
Financials
  TTM Q3 2026 Q2 2026
Basic EPS $5.1 $1.28 $1.2
Diluted EPS $5.07 $1.28 $1.2
Revenue $7.37B $1.88B $1.84B
Gross Profit $3.97B $1.04B $990M
Net Income / Loss $1.44B $362M $339M
Operating Income / Loss $1.64B $444M $399M
Cost of Revenue $3.4B $836M $845M
Net Cash Flow $223M $-49M $49M
PE Ratio    
Splits
Nov 03, 2014 1398:1000